Department of Pharmacy, Tajen University, Pingtung 907, Taiwan.
Department of Medical Research, China Medical University Hospital, China Medical University, Taichung 404, Taiwan.
Sci Rep. 2016 Dec 21;6:39251. doi: 10.1038/srep39251.
For past three decades, numerous studies have elucidated the antiproliferative effects of acetogenins in hopes of developing a new class of clinical anticancer agents. However, clear and definitive action mechanisms of acetogenins were less clarified. In the present study, three tetrahydrofuran (THF)-containing acetogenins were found to have potent and selective antiproliferative activity against human nasopharyngeal carcinoma (NPC) cell lines and their methotrexate-resistant counterparts. The THF-containing acetogenins induced G/M phase arrest, mitochondrial damage and apoptosis, and increased cytosolic and mitochondrial Ca in NPCs. Microarray analysis of NPC-TW01 cells treated with squamostatin A, a non-adjacent bis-THF acetogenin, demonstrated an increased endoplasmic reticulum (ER)-stress response (ESR). Enhanced ESR in squamostatin A-treated cells was confirmed by real-time PCR, Western blot and shRNA gene knockdown experiments. Although our results showed that squamostatin A-induced ESR was independent of extracellular Ca, the presence of extracellular Ca enhanced the antiproliferative effect of acetogenins. In vivo analyses demonstrated that squamostatin A showed good pharmacokinetic properties and significantly retarded NPC tumor growth in the xenograft mouse model. Conclusively, our work demonstrates that acetogenins are effective and selective inducers of the ESR that can block NPC proliferation, and illustrate a previously unappreciated antitumor mechanism of acetogenins that is effective against nasopharyngeal malignancies.
在过去的三十年中,许多研究已经阐明了丙二酰基辅酶 A 还原酶抑制剂的抗增殖作用,希望开发一类新的临床抗癌药物。然而,丙二酰基辅酶 A 还原酶抑制剂的作用机制尚不清楚。在本研究中,发现三种含有四氢呋喃(THF)的丙二酰基辅酶 A 还原酶抑制剂对人鼻咽癌(NPC)细胞系及其甲氨蝶呤耐药株具有很强的选择性抗增殖活性。含有四氢呋喃的丙二酰基辅酶 A 还原酶抑制剂诱导 G/M 期阻滞、线粒体损伤和凋亡,并增加 NPC 中的细胞质和线粒体钙。用 squamostatin A(一种非相邻双 THF 丙二酰基辅酶 A 还原酶抑制剂)处理 NPC-TW01 细胞的微阵列分析显示内质网(ER)应激反应(ESR)增加。实时 PCR、Western blot 和 shRNA 基因敲低实验证实 squamostatin A 处理细胞中的 ESR 增强。虽然我们的结果表明 squamostatin A 诱导的 ESR 不依赖于细胞外 Ca,但细胞外 Ca 的存在增强了丙二酰基辅酶 A 还原酶抑制剂的抗增殖作用。体内分析表明 squamostatin A 具有良好的药代动力学特性,并显著延缓异种移植小鼠模型中 NPC 肿瘤的生长。总之,我们的工作表明,丙二酰基辅酶 A 还原酶抑制剂是内质网应激的有效和选择性诱导剂,可以阻断 NPC 的增殖,并阐明了丙二酰基辅酶 A 还原酶抑制剂对鼻咽癌的一种以前未被认识的抗肿瘤机制。